在阿拉伯和中东人口中,与心脏代谢风险相关的最佳BMI截止值:系统性审查和元分析
Salim Al Busaidi1, Juhaina Salim Al-Maqbali2,3, Jawahar Al Nou'mani1
1Department of Medicine, Sultan Qaboos University Hospital, University Medical City, Muscat, Oman.
International journal of obesity (2005)
|November 25, 2025
概括
下肢体质量指数 (BMI) 值与中东人口的心脏代谢风险有关. 这凸显了需要区域特定的BMI指导方针,以改善与肥胖有关的疾病的早期诊断和管理.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 全球肥胖率的上升需要特定于人口的身体质量指数 (BMI) 门.
- 国际BMI指南可能无法准确评估阿拉伯和中东人口的心脏代谢风险.
研究的目的:
- 在阿拉伯和中东人口中确定心脏代谢发病率和死亡率的最佳BMI截止值.
- 为特定区域的肥胖管理公共卫生战略提供信息.
主要方法:
- 对观察性和实验性研究进行系统审查和元分析.
- 在Medline和Embase数据库中搜索BMI值和心脏代谢结果的研究.
- 利用随机效应模型和PRISMA指导方针进行数据提取和分析.
主要成果:
- 分析了55项涉及677,587名参与者的研究.
- 最佳的BMI截止值在26.22至27.45公斤/平方米之间,糖尿病 (DM),高血压 (HTN) 和代谢综合征 (MetS) 的值较低.
- 观察到BMI截止值的性别差异,女性有更高的值;注意到高异质性.
结论:
- 与全球标准相比,较低的BMI值与此人群中的心脏代谢风险有关.
- 支持制定区域特定的BMI指南,用于早期检测和管理.
- 强调需要针对中东地区肥胖的量身定制的公共卫生干预措施.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
204
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
204
Coronary Artery Disease I: Introduction
857
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
857
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
228
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
228
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K


